I

n a widely anticipated move, a pharmaceutical industry trade group has filed a lawsuit seeking to stifle a new California law that requires drug makers to explain and justify price hikes.

The law has been hailed by supporters as a key attempt to provide transparency into opaque pricing practices amid growing public outrage over the cost of medicines. Not only is the law one of the more comprehensive efforts to address the issue, but California is seen as a bellwether for the rest of the nation and drug makers fear other states will attempt to adopt similar measures.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

X